D-0499-2019 Class III Terminated
FDA drug recall D-0499-2019 was initiated by Advanced Pharma Inc. on Feb 6, 2019 and is designated Class III. Reason for recall: Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label. The recall status is terminated (terminated Oct 30, 2019). Affected quantity: 1460 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 27, 2019
- Initiation Date
- Feb 6, 2019
- Termination Date
- Oct 30, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1460 bottles
Product description
Oxytocin 30 Units added to NS 500 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 503 mL Sterile single use bag, Rx only, Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-706-50.
Reason for recall
Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.
Distribution pattern
Nationwide in the USA.
Code information
Lots: 11/27/18 3177 70650P, BUD: 02/10/2019; 11/27/18 6618 70650P, BUD: 02/10/2019; 11/28/18 7716 70650P, BUD: 02/12/19; 12/31/18 5698 70650P, BUD: 03/16/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0499-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026